Cantor Fitzgerald Has Negative View of ACAD FY2025 Earnings
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Investment analysts at Cantor Fitzgerald reduced their FY2025 EPS estimates for shares of ACADIA Pharmaceuticals in a research report issued to clients and investors on Thursday, May 8th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will post earnings per share of $0.51 for […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Investment analysts at Cantor Fitzgerald reduced their FY2025 EPS estimates for shares of ACADIA Pharmaceuticals in a research report issued to clients and investors on Thursday, May 8th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will post earnings per share of $0.51 for […]
